![Christian Schetter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christian Schetter
Président chez
STipe Therapeutics ApS
Profil
Christian Schetter is currently the Executive Chairman at STipe Therapeutics ApS, Independent Director at OMEICOS Therapeutics GmbH, and a Member of the Management Board at BIO Deutschland.
He previously served as the President & CEO at Neovii Biotech GmbH from 2008 to 2014, CEO & Member of the Supervisory Board at Rigontec GmbH from 2015 to 2018, Senior VP & Managing Director at Coley Pharmaceutical GmbH, and Senior VP-European Operations at Coley Pharmaceutical Group, Inc. He also served as a Director at Aura Biosciences, Inc. and Pyxis Oncology, Inc. and briefly as the Managing Director at Arix Bioscience Plc and Director at Twelve Bio.
Dr. Schetter received his undergraduate and doctorate degrees from Universität zu Köln.
Postes actifs de Christian Schetter
| Sociétés | Poste | Début |
|---|---|---|
BIO Deutschland
 BIO Deutschland Miscellaneous Commercial ServicesCommercial Services Operates as business association for biotechnology industry | Corporate Officer/Principal | - |
OMEICOS Therapeutics GmbH
 OMEICOS Therapeutics GmbH BiotechnologyHealth Technology Develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation | Directeur/Membre du Conseil | 11/02/2019 |
STipe Therapeutics ApS
 STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immune-oncology therapies | Président | 30/09/2019 |
Anciens postes connus de Christian Schetter
| Sociétés | Poste | Fin |
|---|---|---|
| ARIX BIOSCIENCE PLC | Corporate Officer/Principal | 31/08/2021 |
Twelve Bio
 Twelve Bio Miscellaneous Commercial ServicesCommercial Services Provides research and development solutions for therapeutic application | Président | 17/06/2021 |
Rigontec GmbH
 Rigontec GmbH Pharmaceuticals: MajorHealth Technology Provides RNA-based immunotherapeutics for the treatment of cancer and viral diseases | Directeur Général | 31/12/2018 |
Neovii Biotech GmbH
 Neovii Biotech GmbH BiotechnologyHealth Technology Develops and markets biopharmaceutical products | Directeur Général | 01/01/2014 |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat chronic diseases | Corporate Officer/Principal | 03/05/2011 |
Formation de Christian Schetter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
38
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat chronic diseases | Health Technology |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Universität zu Köln
 Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coley Pharmaceutical GmbH
 Coley Pharmaceutical GmbH Miscellaneous Commercial ServicesCommercial Services Provides research and development in the field of natural sciences, engineering, agricultural sciences and medicine | Commercial Services |
Neovii Biotech GmbH
Neovii Biotech GmbH BiotechnologyHealth Technology Develops and markets biopharmaceutical products | Health Technology |
BIO Deutschland
BIO Deutschland Miscellaneous Commercial ServicesCommercial Services Operates as business association for biotechnology industry | Commercial Services |
OMEICOS Therapeutics GmbH
OMEICOS Therapeutics GmbH BiotechnologyHealth Technology Develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation | Health Technology |
Rigontec GmbH
Rigontec GmbH Pharmaceuticals: MajorHealth Technology Provides RNA-based immunotherapeutics for the treatment of cancer and viral diseases | Health Technology |
Arix Bioscience Plc
 Arix Bioscience Plc Investment ManagersFinance Operates as a global venture capital firm | Finance |
Pyxis Oncology, Inc.
 Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immune-oncology therapies | Health Technology |
Twelve Bio
Twelve Bio Miscellaneous Commercial ServicesCommercial Services Provides research and development solutions for therapeutic application | Commercial Services |
